Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
primary studies published RCT
Details- 1997
- Porteous DJ
Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group.
primary studies published RCT
Details- 1997
- Richard DA
Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
primary studies published RCT
Details- 1997
- Robinson M
Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.
primary studies published RCT
Details- 1997
- Schaad UB
Effect of supplemental oxygen on supramaximal exercise performance and recovery in cystic fibrosis.
primary studies published RCT
Details- 1997
- Shah AR
- 1997
- Shah PL
Lower respiratory illness in infants and young children with cystic fibrosis: evaluation of treatment with intravenous hydrocortisone.
primary studies published RCT
Details- 1997
- Tepper RS
Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up.
primary studies published RCT
Details- 1997
- van de Meeberg PC
Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
primary studies published RCT
Details- 1997
- Zabner J
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
primary studies published RCT
Details- 1996
- Colombo C